Stephen G. Ellis

发表

Development of a Network to Test Strategies in Cardiovascular Cell Delivery: The NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN)

T. Henry, S. Ellis, C. Pepine, 2010, Journal of cardiovascular translational research.

Drug‐eluting stents versus bare‐metal stents for treatment of bare‐metal in‐stent restenosis

Inder Singh, M. Shishehbor, Eiran Z. Gorodeski, 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Long term follow‐up of drug eluting versus bare metal stents in the treatment of saphenous vein graft lesions

E. Ribeiro, S. Ellis, P. Lemos, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Clinical outcomes of drug‐eluting versus bare‐metal in‐stent restenosis

Inder Singh, M. Shishehbor, Eiran Z. Gorodeski, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Associations Between Cardiac Troponin, Mechanism of Myocardial Injury, and Long‐Term Mortality After Noncardiac Vascular Surgery

S. Ellis, A. Lincoff, S. Nissen, 2017, Journal of the American Heart Association.

Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. PLAC I investigation.

S. Ellis, B. Pitt, M. McGovern, 1995, Journal of the American College of Cardiology.

Frequency and long-term impact of myonecrosis after coronary stenting.

E. Topol, S. Ellis, S. Brener, 2002, European heart journal.

Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group.

E J Topol, E. Topol, S. Ellis, 1990, Circulation.

Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial.

R. Califf, E. Topol, C. Granger, 1999, Circulation.

Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction.

E. Ribeiro, E. Buffolo, L. Silva, 1993, Journal of the American College of Cardiology.

Early Risk of Mortality After Coronary Artery Revascularization in Patients With Left Ventricular Dysfunction and Potential Role of the Wearable Cardioverter Defibrillator

M. Chung, N. Smedira, P. Tchou, 2013, Circulation. Arrhythmia and electrophysiology.

Effect of age on outcome with primary angioplasty versus thrombolysis.

R. Califf, E. Topol, H. White, 1999, Journal of the American College of Cardiology.

Low-normal or excessive body mass index: newly identified and powerful risk factors for death and other complications with percutaneous coronary intervention.

S. Ellis, M. Horrigan, R. Raymond, 1996, The American journal of cardiology.

Characterization of Internal Pudendal Artery Atherosclerosis Using Aortography and Multi-Detector Computed Angiography

M. Desai, P. Schoenhagen, S. Ellis, 2013 .

Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction.

E. Topol, R. Erbel, S. Ellis, 1994, Circulation.

End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic Investigators.

David P Miller, R. Califf, E. Topol, 1997, Circulation.

Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries.

E. Topol, P. Serruys, S. Ellis, 1996, Circulation.

Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions.

E. Topol, S. Ellis, P. Whitlow, 1996, Circulation.

A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction.

K. Lee, R. Califf, E. Topol, 1989, Circulation.

Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions

S. Bailey, U. Khot, L. Mauri, 2011 .

Association of adoption of transradial access for percutaneous coronary intervention in ST elevation myocardial infarction with door‐to‐balloon time

S. Ellis, S. Kapadia, U. Khot, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Angiographic correlates of cardiac death and myocardial infarction complicating major nonthoracic vascular surgery.

S. Ellis, S. Brener, N. Hertzer, 1996, The American journal of cardiology.

Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction.

C. Grines, S. Ellis, V. Guetta, 2001, The American journal of cardiology.

Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. EPIC and EPILOG Investigators. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation of PTCA To Improve Long-term Outcome with abciximab GPIIb/IIIa Receptor Block

David P Miller, R. Califf, E. Topol, 1998, Journal of the American College of Cardiology.

Local drug delivery for the prevention of restenosis. Fact, fancy, and future.

E J Topol, E. Topol, S. Ellis, 1994, Circulation.

Does intracoronary thrombus influence the outcome of high risk percutaneous transluminal coronary angioplasty? Clinical and angiographic outcomes in a large multicenter trial. EPIC Investigators. Evaluation of IIb/IIIa Platelet Receptor Antagonist 7E3 in Preventing Ischemic Complications.

R. Califf, E. Topol, H. Weisman, 1998, Journal of the American College of Cardiology.

Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial.

G. Stone, S. Ellis, R. Mehran, 2005, Journal of the American College of Cardiology.

Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.

R. Califf, E. Topol, S. Ellis, 1999, The New England journal of medicine.

A Comparison of Directional Atherectomy with Coronary Angioplasty in Patients with Coronary Artery Disease

R. Califf, D. Mark, E. Topol, 1993 .

Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile.

E. Topol, S. Ellis, A. Lincoff, 1992, Journal of the American College of Cardiology.

Present status of rescue coronary angioplasty: current polarization of opinion and randomized trials.

E. Topol, S. Ellis, F. Werf, 1992, Journal of the American College of Cardiology.

Risk factors, time course and treatment effect for restenosis after successful percutaneous transluminal coronary angioplasty of chronic total occlusion.

E. Topol, S. Ellis, J. Douglas, 1989, The American journal of cardiology.

Comparison of stenting and balloon angioplasty for narrowings in aortocoronary saphenous vein conduits in place for more than five years.

E. Topol, M. Leon, S. Ellis, 1997, The American journal of cardiology.

Importance of stenosis morphology in the estimation of restenosis risk after elective percutaneous transluminal coronary angioplasty.

S. Ellis, J. Douglas, S. King, 1989, The American journal of cardiology.

Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty.

S. Ellis, W. Weintraub, J. Douglas, 1988, Circulation.

Clinical success, complications and restenosis rates with excimer laser coronary angioplasty. The Percutaneous Excimer Laser Coronary Angioplasty Registry.

S. Ellis, J. Tcheng, J. Bittl, 1992, The American journal of cardiology.

Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.

K. Lee, R. Califf, E. Topol, 1991, American heart journal.

Severe aortic stenosis and coronary artery disease--implications for management in the transcatheter aortic valve replacement era: a comprehensive review.

E. Tuzcu, B. Lytle, L. Svensson, 2013, Journal of the American College of Cardiology.

Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures.

E. Topol, S. Ellis, D. Muller, 1992, The American journal of cardiology.

Late myocardial ischemic events after saphenous vein graft intervention--importance of initially "nonsignificant" vein graft lesions.

E. Topol, E. Tuzcu, S. Ellis, 1997, The American journal of cardiology.

CORONARY ARTERY DISEASE Original Studies Real-World Bare Metal Stenting: Identification of Patients at Low or Very Low Risk of 9-Month Coronary Revascularization

Deepak L. Bhatt, E. Topol, E. Tuzcu, 2004 .

Coronary angioplasty as primary therapy for acute myocardial infarction 6 to 48 hours after symptom onset: report of an initial experience.

E. Topol, W. O’Neill, E. Nabel, 1989, Journal of the American College of Cardiology.

In-hospital cardiac mortality after acute closure after coronary angioplasty: analysis of risk factors from 8,207 procedures.

S. Ellis, J. Douglas, S. King, 1988, Journal of the American College of Cardiology.

Analysis and comparison of operator-specific outcomes in interventional cardiology. From a multicenter database of 4860 quality-controlled procedures.

E. Topol, S. Ellis, J. Bittl, 1996, Circulation.

Prediction of risk of anterior myocardial infarction by lesion severity and measurement method of stenoses in the left anterior descending coronary distribution: a CASS Registry Study.

S. Ellis, M. Bourassa, L. Fisher, 1988, Journal of the American College of Cardiology.

Prognostic value of absolute versus relative measures of the procedural result after successful coronary stenting: importance of vessel size in predicting long-term freedom from target vessel revascularization.

E. Tuzcu, S. Ellis, S. Kapadia, 2001, American heart journal.

Percutaneous Coronary Intervention in Patients With Severe Aortic Stenosis: Implications for Transcatheter Aortic Valve Replacement

E. Tuzcu, L. Svensson, S. Ellis, 2012, Circulation.

Ten-fold augmentation of endothelial uptake of vascular endothelial growth factor with ultrasound after systemic administration.

J D Thomas, J. Thomas, James D. Thomas, 2000, Journal of the American College of Cardiology.

Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication.

David P Miller, R. Califf, E. Topol, 1997, JAMA.

Impact of the Duett sealing device on quality of life and hospitalization costs for coronary diagnostic and interventional procedures: Results from the Study of Economic and Quality of Life substudy of the SEAL trial.

T. Feldman, W. Weintraub, E. Mahoney, 2001, American heart journal.

Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade.

E. Topol, E. Tuzcu, S. Ellis, 2000, The American journal of cardiology.

Importance of Abnormal Chloride Homeostasis in Stable Chronic Heart Failure

S. Ellis, W. Tang, F. Verbrugge, 2016, Circulation. Heart failure.

A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. CAVEAT-II Investigators.

R. Califf, E. Topol, D. Holmes, 1995, Circulation.

Plaque vulnerability, plaque rupture, and acute coronary syndromes: (multi)-focal manifestation of a systemic disease process.

Paul Schoenhagen, E. Tuzcu, P. Schoenhagen, 2002, Circulation.

Comparison of three coronary stents: clinical and angiographic outcome after elective placement in 134 consecutive patients.

E. Topol, S. Ellis, P. Whitlow, 1994, Catheterization and cardiovascular diagnosis.

Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.

P. Teirstein, G. Stone, S. Ellis, 2015, The New England journal of medicine.

Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences.

S. Ellis, M. Nobuyoshi, C. Spaulding, 2000, American heart journal.

Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model.

E. Topol, S. Ellis, A. Lincoff, 1995, Circulation.

Prognostic Value of Estimated Functional Capacity Incremental to Cardiac Biomarkers in Stable Cardiac Patients

E. Topol, S. Hazen, S. Ellis, 2014, Journal of the American Heart Association.

Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955--1977.

M. Verity, S. Ellis, Stephen G. Ellis, 1979, Seminars in arthritis and rheumatism.

Studies of experimental coronary artery reperfusion. Effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage.

E. Braunwald, R. Kloner, S. Ellis, 1983, Circulation.

Time course of functional and biochemical recovery of myocardium salvaged by reperfusion.

E. Braunwald, C. Henschke, R. Kloner, 1983, Journal of the American College of Cardiology.

Frequency and factors associated with inappropriate for intervention cardiac catheterization laboratory activation.

E. Tuzcu, S. Ellis, S. Kapadia, 2016, Cardiovascular revascularization medicine : including molecular interventions.

The transcription factor GATA-2 does not associate with angiographic coronary artery disease in the Ottawa Heart Genomics and Cleveland Clinic GeneBank Studies

S. Hazen, S. Ellis, R. McPherson, 2009, Human Genetics.

Evidence that angiotensin-converting enzyme inhibitor use diminishes the need for coronary revascularization after stenting.

E. Topol, S. Ellis, A. Lincoff, 2002, The American journal of cardiology.

Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences.

M. Nobuyoshi, C. Spaulding, B. Weiner, 2000, American heart journal.

Thrombolytic therapy for women with myocardial infarction: is there a gender gap? Thrombolysis and Angioplasty in Myocardial Infarction Study Group.

K. Lee, R. Califf, E. Topol, 1993, Journal of the American College of Cardiology.

Infarction: Phase I Clinical Study Derived Adherent Stem Cell in Acute - Adventitial Delivery of an Allogeneic Bone Marrow

Z. Hodes, A. Ting, Sanjay Gandhi, 2012 .

Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.

K. Lee, R. Califf, E. Topol, 1990, American heart journal.

Thrombosis of a flexible coil coronary stent: frequency, predictors and clinical outcome.

E. Topol, S. Ellis, U. Rosenschein, 1993, Journal of the American College of Cardiology.

Cause of death within 30 days of percutaneous coronary intervention in an era of mandatory outcome reporting.

E. Tuzcu, S. Ellis, M. Shishehbor, 2013, Journal of the American College of Cardiology.

Enhanced prediction of mortality after percutaneous coronary intervention by consideration of general and neurological indicators.

E. Tuzcu, S. Ellis, M. Shishehbor, 2011, JACC. Cardiovascular interventions.

Long term follow‐up of drug eluting versus bare metal stents in the treatment of saphenous vein graft lesions

E. Ribeiro, P. Lemos, H. Ribeiro, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Is traditionally defined complete revascularization needed for patients with multivessel disease treated by elective coronary angioplasty? Multivessel Angioplasty Prognosis Study (MAPS) Group.

E. Topol, S. Ellis, P. Whitlow, 1993, Journal of the American College of Cardiology.

Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: the integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trial.

E. Topol, E. Ohman, S. Ellis, 2002, Journal of the American College of Cardiology.

End‐stage renal disease as an independent risk factor for in‐hospital mortality after coronary drug‐eluting stenting: Understanding and modeling the risk

E. Tuzcu, S. Ellis, S. Kapadia, 2020, Catheterization and cardiovascular interventions.

Percutaneous support devices for high risk or complicated coronary angioplasty.

E. Topol, S. Ellis, A. Lincoff, 1991, Journal of the American College of Cardiology.

The duration of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure-related non-Q-wave myocardial infarctions.

S. Steinhubl, E. Topol, M. Lauer, 1998, Journal of the American College of Cardiology.

Morphology of left anterior descending coronary territory lesions as a predictor of anterior myocardial infarction: a CASS Registry Study.

S. Ellis, M. Bourassa, L. Fisher, 1989, Journal of the American College of Cardiology.

Long-term outcome of transient, uncomplicated in-laboratory coronary artery closure.

E. Topol, S. Ellis, P. Whitlow, 1995, Circulation.

A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction.

E. Topol, E. Nabel, M. Schwaiger, 1991, Journal of the American College of Cardiology.

Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group.

K. Lee, R. Califf, E. Topol, 1995, The American journal of cardiology.

High-risk coronary atheroma: the interplay between ischemia, plaque burden, and disease progression.

E. Tuzcu, S. Ellis, S. Kapadia, 2014, Journal of the American College of Cardiology.

Cardiogenic shock complicating acute myocardial infarction: the use of coronary angioplasty and the integration of the new support devices into patient management.

E. Topol, S. Ellis, E. Bates, 1992, Journal of the American College of Cardiology.

Clinical risk factors for ischemic complications after percutaneous coronary interventions: Results from the EPIC trial

R. Califf, E. Topol, S. Ellis, 1999 .

A strategy to arrest and reverse coronary artery disease: a 5-year longitudinal study of a single physician's practice.

S. Medendorp, S. Ellis, T. Crowe, 1995, The Journal of family practice.

Results of percutaneous transluminal coronary angioplasty of high-risk angulated stenoses.

E. Topol, S. Ellis, Stephen G. Ellis, 1990, The American journal of cardiology.

Clinical angiographic and histologic correlates of ectasia after directional coronary atherectomy.

E. Topol, S. King, D. Holmes, 1992, The American journal of cardiology.

Spectrum of surgical risk for left main coronary stenoses: benchmark for potentially competing percutaneous therapies.

B. Lytle, S. Ellis, C. Hill, 1998, American heart journal.